295 related articles for article (PubMed ID: 23150673)
1. C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity.
Benoit ME; Hernandez MX; Dinh ML; Benavente F; Vasquez O; Tenner AJ
J Biol Chem; 2013 Jan; 288(1):654-65. PubMed ID: 23150673
[TBL] [Abstract][Full Text] [Related]
2. The regulation of p53 up-regulated modulator of apoptosis by JNK/c-Jun pathway in β-amyloid-induced neuron death.
Akhter R; Sanphui P; Das H; Saha P; Biswas SC
J Neurochem; 2015 Sep; 134(6):1091-103. PubMed ID: 25891762
[TBL] [Abstract][Full Text] [Related]
3. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.
Zhou J; Fonseca MI; Pisalyaput K; Tenner AJ
J Neurochem; 2008 Sep; 106(5):2080-92. PubMed ID: 18624920
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q.
Webster SD; Galvan MD; Ferran E; Garzon-Rodriguez W; Glabe CG; Tenner AJ
J Immunol; 2001 Jun; 166(12):7496-503. PubMed ID: 11390503
[TBL] [Abstract][Full Text] [Related]
5. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
6. Effects of incorporation of immunoglobulin G and complement component C1q on uptake and degradation of Alzheimer's disease amyloid fibrils by microglia.
Brazil MI; Chung H; Maxfield FR
J Biol Chem; 2000 Jun; 275(22):16941-7. PubMed ID: 10747968
[TBL] [Abstract][Full Text] [Related]
7. Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease.
Ager RR; Fonseca MI; Chu SH; Sanderson SD; Taylor SM; Woodruff TM; Tenner AJ
J Neurochem; 2010 Apr; 113(2):389-401. PubMed ID: 20132482
[TBL] [Abstract][Full Text] [Related]
8. Induction of complement proteins in a mouse model for cerebral microvascular A beta deposition.
Fan R; DeFilippis K; Van Nostrand WE
J Neuroinflammation; 2007 Sep; 4():22. PubMed ID: 17877807
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.
Bergamaschini L; Canziani S; Bottasso B; Cugno M; Braidotti P; Agostoni A
Clin Exp Immunol; 1999 Mar; 115(3):526-33. PubMed ID: 10193429
[TBL] [Abstract][Full Text] [Related]
10. Complement C1q expression induced by Abeta in rat hippocampal organotypic slice cultures.
Fan R; Tenner AJ
Exp Neurol; 2004 Feb; 185(2):241-53. PubMed ID: 14736505
[TBL] [Abstract][Full Text] [Related]
11. Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation.
Li M; Ager RR; Fraser DA; Tjokro NO; Tenner AJ
Mol Immunol; 2008 Jun; 45(11):3244-52. PubMed ID: 18400300
[TBL] [Abstract][Full Text] [Related]
12. Expression of complement system components during aging and amyloid deposition in APP transgenic mice.
Reichwald J; Danner S; Wiederhold KH; Staufenbiel M
J Neuroinflammation; 2009 Nov; 6():35. PubMed ID: 19917141
[TBL] [Abstract][Full Text] [Related]
13. Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms.
Pisalyaput K; Tenner AJ
J Neurochem; 2008 Feb; 104(3):696-707. PubMed ID: 17986223
[TBL] [Abstract][Full Text] [Related]
14. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
Mulder SD; Veerhuis R; Blankenstein MA; Nielsen HM
Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
[TBL] [Abstract][Full Text] [Related]
15. Neuronal localization of C1q in preclinical Alzheimer's disease.
Fonseca MI; Kawas CH; Troncoso JC; Tenner AJ
Neurobiol Dis; 2004 Feb; 15(1):40-6. PubMed ID: 14751769
[TBL] [Abstract][Full Text] [Related]
16. Binding of proteases to fibrillar amyloid-beta protein and its inhibition by Congo red.
Chander H; Chauhan A; Chauhan V
J Alzheimers Dis; 2007 Nov; 12(3):261-9. PubMed ID: 18057560
[TBL] [Abstract][Full Text] [Related]
17. C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease.
Luo X; Weber GA; Zheng J; Gendelman HE; Ikezu T
J Neuroimmunol; 2003 Feb; 135(1-2):62-71. PubMed ID: 12576225
[TBL] [Abstract][Full Text] [Related]
18. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
19. Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression.
Benoit ME; Tenner AJ
J Neurosci; 2011 Mar; 31(9):3459-69. PubMed ID: 21368058
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of C1q-beta-amyloid binding protects hippocampal cells against complement mediated toxicity.
Sárvári M; Vágó I; Wéber CS; Nagy J; Gál P; Mák M; Kósa JP; Závodszky P; Pázmány T
J Neuroimmunol; 2003 Apr; 137(1-2):12-8. PubMed ID: 12667643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
